Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Matsui Y et al. – The data showed that the combination of olmesartan and azelnidipine had a more beneficial effect on central systolic BP and arterial stiffness than the combination of olmesartan (20.0 mg) and hydrochlorothiazide, despite the lack of a significant difference in brachial systolic BP reduction between the 2 treatments.

Exclusive Author Commentary
Yoshio Matsui, 08/16/09

The J-CORE study demonstrated that both the change in the pattern of arterial wave reflections and the decrease in arterial stiffness might contribute to a greater reduction in central SBP with the ARB/CCB treatment. Recently, the ACCOMPLISH study demonstrated that the combination of an ACE-I and a CCB was more effective than the combination of an ACE-I and a thiazide diuretic for decreasing cardiovascular events in high-risk hypertensive patients. Benefits were seen despite trivial differences in brachial SBP. Such a discrepancy between the difference of brachial SBP and clinical outcome was seen in the CAFÉ study and this was explained by the difference of central SBP. Because the central SBP and aortic PWV are independent predictors of cardiovascular morbidity in hypertensive patients, the benefits of the ACE-I/CCB combination in the ACCOMPLISH study may be attributable to a greater reduction in central SBP and arterial stiffness beyond the reduction in brachial SBP compared with that by the ACE-I/diuretic combination.

Today in Hypertension...keeping you current

Role of rho-kinase in the regulation of vascular tone in hypertensive renal transplant recipients
Atherosclerosis, 12/04/09

O-GlcNAcylation Contributes to Augmented Vascular Reactivity Induced by Endothelin
Hypertension, 12/03/09

Blood pressure in children and target-organ damage later in life
Pediatric Nephrology, 12/03/09

Today in Pharmacology/kinetics...keeping you current

Medium-size-vessel vasculitis
Pediatric Nephrology, 12/04/09

Sirolimus and Cyclosporine A Alter Barrier Function In Renal Proximal Tubular Cells through Stimulation of ERK 1/2 Signaling and Claudin-1 Expression
American Journal of Physiology: Renal Physiology, 12/04/09

Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation
Urologic Oncology: Seminars and Original Investigations, 12/03/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address